UPDATE: Piper Jaffray Downgrades Transcept Pharmaceuticals (TSPT) to Neutral
Tweet Send to a Friend
(Updated - April 11, 2013 11:25 AM EDT)
Piper Jaffray downgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from Overweight to Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Jaffray downgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from Overweight to Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
